Current News Thursday, March 11, 2010 Biotech Pharma
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer
ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief... more
Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project
Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles... more
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
PR Newswire
AMSTERDAM, March 10,... more
YM BioSciences closes US$17.5 million financing
YM BioSciences closes US$17.5 million financing
PR Newswire
MISSISSAUGA, ON, March 10... more
Multi-Cultural
Sodexo Ranked Number One Company for Diversity by DiversityInc
Sodexo Ranked Number One Company for Diversity by DiversityInc
Also ranked as best for executive... more
Ogilvy Hosts 'Blacks In Tech Panel' At SXSW
Ogilvy Hosts 'Blacks In Tech Panel' At SXSW
DISCUSSION TO LOOK AT THE IMPACT OF MULTICULTURALISM... more
Ruder Finn's Travel Practice EVP Gail Moaney Named Among Top Twenty-Five Influential Black Women in Business
Ruder Finn's Travel Practice EVP Gail Moaney Named Among Top Twenty-Five Influential Black Women... more
CCSA Finance Ltd. Announces Preliminary Results for its Tender Offer and Receipt of Requisite Consents in its Consent Solicitation for its 7.875% Notes Due 2016
CCSA Finance Ltd. Announces Preliminary Results for its Tender Offer and Receipt of Requisite... more
FDA
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia
Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for... more
Pulmonary Fibrosis Patient Organizations Applaud Efforts of Patients, Families at FDA Hearing
Pulmonary Fibrosis Patient Organizations Applaud Efforts of Patients, Families at FDA Hearing
PR... more
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Premium Lens... more
FDA Advisory Committee Recommends Approval of InterMune's Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
FDA Advisory Committee Recommends Approval of InterMune's Esbriet(R) (pirfenidone) for Idiopathic... more
|